Mikrobiomik
Operator of a biopharmaceutical company intended to research, develop, produce, and market biological drugs based on the human microbiome. The company's biological medicine treats both the primary epi...
Valuation
$16.7M
Market implied
Share Price
N/A
Total Raised
$10.3M
Last Round
N/A